IR-Med Inc. (IRME)
OTCMKTS · Delayed Price · Currency is USD
0.0010
-0.0021 (-67.74%)
At close: Jan 30, 2026

IR-Med Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
0.060.130.7732.821.87
Cash & Short-Term Investments
0.060.130.7732.821.87
Cash Growth
-91.63%-83.18%-74.45%6.64%50.86%694.04%
Other Receivables
-0.050.050.040.070.03
Receivables
0.030.050.050.040.070.03
Prepaid Expenses
-0.020.030.0100
Other Current Assets
-----0.19
Total Current Assets
0.090.210.853.062.882.08
Property, Plant & Equipment
0.070.040.140.230.030.01
Other Long-Term Assets
0.010.010.010.010.03-
Total Assets
0.180.2513.292.942.09
Accounts Payable
0.070.060.060.070.060.03
Accrued Expenses
0.170.310.260.250.310.48
Current Portion of Long-Term Debt
0.180.16-0.16--
Current Portion of Leases
0.02-0.040.07--
Other Current Liabilities
0.140.020.110.110.030.02
Total Current Liabilities
0.770.550.470.660.40.52
Long-Term Debt
--0.16-0.180.17
Long-Term Leases
0.03--0.04--
Total Liabilities
0.80.550.630.70.570.69
Common Stock
0.080.070.070.070.060.05
Additional Paid-In Capital
17.5116.3715.1412.457.52.83
Retained Earnings
-18.21-16.74-14.84-9.93-5.2-1.48
Shareholders' Equity
-0.63-0.290.372.592.371.4
Total Liabilities & Equity
0.180.2513.292.942.09
Total Debt
0.250.160.20.280.180.17
Net Cash (Debt)
-0.19-0.030.572.732.641.7
Net Cash Growth
---79.20%3.34%55.18%1831.82%
Net Cash Per Share
-0.00-0.000.010.040.040.06
Filing Date Shares Outstanding
77.2472.0169.9368.8164.664.6
Total Common Shares Outstanding
77.2471.0169.9368.8164.653.59
Working Capital
-0.68-0.340.382.42.491.56
Book Value Per Share
-0.01-0.000.010.040.040.03
Tangible Book Value
-0.63-0.290.372.592.371.4
Tangible Book Value Per Share
-0.01-0.000.010.040.040.03
Machinery
-0.070.070.070.040.01
Leasehold Improvements
-0.020.020.020-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.